This trial is testing a new device that removes clots in people with acute ischemia (lack of blood flow).
1 Primary · 1 Secondary · Reporting Duration: 90 days
Experimental Treatment
15 Total Participants · 1 Treatment Group
Primary Treatment: neurological thrombectomy device is an investigational device. · No Placebo Group · N/A
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: